Daphne Jones - AMN Healthcare Independent Director
| AMN Stock | USD 27.16 1.32 5.11% |
Director
Ms. Daphne E. Jones is Independent Director of the Company. Ms. Jones is qualified to serve on the Board because she brings considerable information technology, global digital technology use, data management and privacy experience as a seasoned Csuite executive with extensive experience in multinational corporations. Ms. Jones digital use and technology expertise and experience will be critical to our successful execution of our digital strategies. Ms. Jones served as the Senior Vice President DigitalFuture of Work for GE Healthcare, the healthcare business of GE, from May 2017 to October 2017 and prior to that she served as the Senior Vice President Chief Information Officer for GE Healthcare Diagnostic Imaging and Services since August 2014. Prior to joining GE Healthcare, Ms. Jones was the Senior Vice President, Chief Information Officer for Hospira, Inc., a provider of pharmaceuticals and infusion technologies, from October 2009 through June 2014. Previously she served as Chief Information Officer at Johnson Johnson from 2006 to 2009 and served in various information technology roles with Johnson Johnson from 1997 through 2006 since 2018.
| Age | 64 |
| Tenure | 6 years |
| Address | 8840 Cypress Waters Boulevard, Dallas, TX, United States, 75019 |
| Phone | 866 871 8519 |
| Web | https://www.amnhealthcare.com |
AMN Healthcare Management Efficiency
The company has Return on Asset of 0.0315 % which means that on every $100 spent on assets, it made $0.0315 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0621 %, implying that it generated $0.0621 on every 100 dollars invested. AMN Healthcare's management efficiency ratios could be used to measure how well AMN Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. At this time, AMN Healthcare's Return On Tangible Assets are very stable compared to the past year. As of the 26th of November 2024, Return On Assets is likely to grow to 0.08, while Return On Capital Employed is likely to drop 0.1. At this time, AMN Healthcare's Intangibles To Total Assets are very stable compared to the past year. As of the 26th of November 2024, Return On Assets is likely to grow to 0.08, while Other Assets are likely to drop 0.95.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Nancy Schlichting | Encompass Health Corp | 66 | |
| John Chidsey | Encompass Health Corp | 58 | |
| Yvonne Curl | Encompass Health Corp | 65 | |
| William Frist | Select Medical Holdings | 69 | |
| Maria Singer | Universal Health Services | 46 | |
| John Maupin | Encompass Health Corp | 73 | |
| Charles Elson | Encompass Health Corp | 60 | |
| Thomas Scully | Select Medical Holdings | 63 | |
| Parvinderjit Khanuja | Select Medical Holdings | 62 | |
| Elliot Sussman | Universal Health Services | 68 | |
| Daniel Thomas | Select Medical Holdings | 62 | |
| Marilyn Tavenner | Select Medical Holdings | 69 | |
| James Ely | Select Medical Holdings | 63 | |
| Eileen McDonnell | Universal Health Services | 57 | |
| Donald Correll | Encompass Health Corp | 70 | |
| Katherine Davisson | Select Medical Holdings | 53 | |
| Christopher Reidy | Encompass Health Corp | 64 | |
| Bryan Cressey | Select Medical Holdings | 71 | |
| Warren Nimetz | Universal Health Services | 64 | |
| Lawrence Gibbs | Universal Health Services | 48 | |
| Leslye Katz | Encompass Health Corp | 66 | |
Management Performance
| Return On Equity | 0.0621 | ||||
| Return On Asset | 0.0315 |
AMN Healthcare Services Leadership Team
Elected by the shareholders, the AMN Healthcare's board of directors comprises two types of representatives: AMN Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AMN. The board's role is to monitor AMN Healthcare's management team and ensure that shareholders' interests are well served. AMN Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AMN Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| R Harris, Independent Director | ||
| Cole Edmonson, Chief Experience and Clinical Officer | ||
| Nishan Sivathasan, Division Solutions | ||
| Mark Foletta, Independent Director | ||
| Landry Seedig, Group President and Chief Operating Officer, Nurse and Allied Solutions | ||
| Julie Fletcher, Chief Officer | ||
| Randle Reece, IR Contact Officer | ||
| Kelly Rakowski, Group President and Chief Operating Officer, Strategic Talent Solutions | ||
| Jeffrey Knudson, Chief Financial Officer, Chief Accounting Officer | ||
| Meredith Lapointe, Chief Officer | ||
| Patrick McCall, Chief Officer | ||
| Brian Scott, Chief Financial Officer, Chief Accounting Officer, Treasurer | ||
| Teri Fontenot, Independent Director | ||
| Whitney Laughlin, Corporate Officer | ||
| Christopher Schwartz, Principal Financial Officer | ||
| Denise Jackson, Senior Vice President, General Counsel, Secretary | ||
| Michael Johns, Independent Director | ||
| Julie Purinton, Division Nurse | ||
| Susan Salka, CEO and President Director and Member of Executive Committee | ||
| James Taylor, Group President and Chief Operating Officer for Physician & Leadership Solutions | ||
| Kimberly Martini, Division Solutions | ||
| Jorge Caballero, Independent Director | ||
| Martha Marsh, Independent Director | ||
| Mark Hagan, Chief Information Office and Digital Officer, Executive Officer | ||
| Robin Johnson, Group Solutions | ||
| Sylvia TrentAdams, Independent Director | ||
| Douglas Wheat, Independent Chairman of the Board | ||
| Caroline Grace, CEO President | ||
| Carolyn Kenny, Chief Officer | ||
| Jeff Decker, Division Solutions | ||
| Daphne Jones, Independent Director |
AMN Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AMN Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0621 | ||||
| Return On Asset | 0.0315 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 2.13 B | ||||
| Shares Outstanding | 38.07 M | ||||
| Shares Owned By Insiders | 0.75 % | ||||
| Shares Owned By Institutions | 99.25 % | ||||
| Number Of Shares Shorted | 4.2 M | ||||
| Price To Earning | 12.02 X |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AMN Healthcare Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AMN Healthcare. If investors know AMN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AMN Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.87) | Earnings Share 1.43 | Revenue Per Share 80.434 | Quarterly Revenue Growth (0.19) | Return On Assets 0.0315 |
The market value of AMN Healthcare Services is measured differently than its book value, which is the value of AMN that is recorded on the company's balance sheet. Investors also form their own opinion of AMN Healthcare's value that differs from its market value or its book value, called intrinsic value, which is AMN Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AMN Healthcare's market value can be influenced by many factors that don't directly affect AMN Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AMN Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if AMN Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AMN Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.